KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Procter & Gamble (PG) EBIAT (2016 - 2025)

Procter & Gamble (PG) has disclosed EBIAT for 17 consecutive years, with $4.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, EBIAT fell 6.46% to $4.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $16.5 billion, a 6.09% increase, with the full-year FY2025 number at $16.1 billion, up 7.97% from a year prior.
  • EBIAT was $4.3 billion for Q4 2025 at Procter & Gamble, down from $4.8 billion in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $4.8 billion in Q3 2025 to a low of $3.0 billion in Q2 2021.
  • A 5-year average of $3.8 billion and a median of $3.7 billion in 2024 define the central range for EBIAT.
  • Peak YoY movement for EBIAT: decreased 11.82% in 2023, then surged 33.51% in 2024.
  • Procter & Gamble's EBIAT stood at $4.2 billion in 2021, then fell by 6.87% to $3.9 billion in 2022, then decreased by 11.82% to $3.5 billion in 2023, then skyrocketed by 33.51% to $4.6 billion in 2024, then dropped by 6.46% to $4.3 billion in 2025.
  • Per Business Quant, the three most recent readings for PG's EBIAT are $4.3 billion (Q4 2025), $4.8 billion (Q3 2025), and $3.6 billion (Q2 2025).